Cancer
Therapeutics Market Significant Players, Trends in Future, Revenue, Application
(2021-2031)

The cancer therapeutics market size is expected to reach
US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The
market is estimated to record a CAGR of 12.8% from 2025 to 2031.

Executive Summary and Global Market Analysis

The global cancer therapeutics market is experiencing steady
growth, primarily propelled by the increasing incidence of breast and lung
cancers, coupled with significant investments in oncology research and
development. Cancer therapeutics encompass a diverse range of treatments
designed to combat or cure cancer. Key therapeutic modalities commonly employed
include chemotherapy, radiation therapy, immunotherapy, targeted therapy,
hormone therapy, surgical interventions, and stem cell therapy. The overarching
aim of these strategies is to eliminate or control cancerous cells, alleviate
symptoms, and ultimately enhance patient quality of life and survival rates.
Treatment protocols often involve a combination of multiple therapies,
meticulously personalized to the specific type and stage of cancer, as well as
the patient's overall health, to achieve optimal outcomes.

Cancer Therapeutics Market
Segmentation Analysis

The cancer therapeutics market is broken down into three
essential segments: therapy type, indication, and distribution channel.

By therapy type, the market is categorized into
chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other
therapeutic approaches. Chemotherapy held the largest market share in 2024.

Regarding indications, the market covers blood cancer, lung
cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer,
cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and
other specific indications. Lung cancer represented the largest share of the
market in 2024.

In terms of distribution channel, the market segments are
hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies
maintained the largest share of the market in 2024.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00031299

Cancer Therapeutics Market Drivers and Opportunities

As per the World Health Organization, various forms of
cancer are responsible for approximately 1 in every 6 deaths globally. In 2022,
there were an estimated 20 million new cancer diagnoses and 9.7 million
cancer-related deaths. This disease burden is projected to increase by
approximately 77% by 2050, which will exert significant pressure on global
healthcare systems and communities. The American Cancer Society reports that
5–10% of all cancers are inherited from parental lineage. A substantial number
of genes associated with cancer predisposition have been identified. For
example, mutations in hereditary cancer susceptibility genes such as BRCA1 and
BRCA2 significantly increase the risk of developing various cancers, including
breast, ovarian, and prostate cancer. Breast cancer is globally recognized as
the most prevalent cancer among women, with its incidence continuously rising
due to contributing factors like environmental exposure, genetic
susceptibility, hormonal imbalances, and evolving lifestyle choices.
Additionally, breast cancer remains one of the most frequently diagnosed
cancers in the U.S.

Cancer Therapeutics Market Size and Share Analysis

Based on therapy type, the cancer therapeutics market is
segmented into chemotherapy, targeted therapy, radiation therapy, hormone
therapy, and other therapy types. The chemotherapy segment held the dominant
market position in 2024. Chemotherapy agents, through their cytotoxic action,
effectively halt or slow the proliferation of cancer cells. These drugs are
systemically delivered via the bloodstream, targeting and disrupting cancer
cell growth throughout the body. According to National Institutes of Health
estimates, approximately 650,000 cancer patients in the US undergo chemotherapy
treatment annually in specialized oncology clinics.

Concerning indications, the market is segmented into blood
cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach
cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid
cancer, and other indications. The lung cancer segment commanded the largest
share of the market in 2024.

About Us:

Business Market Insights is a market research platform that
provides subscription service for industry and company reports. Our research
team has extensive professional expertise in domains such as Electronics &
Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy
& Power; Healthcare; Manufacturing & Construction; Food &
Beverages; Chemicals & Materials; and Technology, Media, &
Telecommunications